OVEREXPRESSION OF ISOCITRATE DEHYDROGENASE 1/2 (IDH1/2) MUTANT PROTEIN RENDERS GLIOMA CELLS MORE SENSITIVE TO RADIATION

被引：0
|
作者：
Li, Sichen [1 ]
Chou, Arthur P. [1 ]
Chen, Weidong [1 ]
Chen, Ruihuan [2 ]
Deng, Yuzhong [2 ]
Phillips, Heidi S. [2 ]
Faull, Kym F. [1 ]
Cloughesy, Timothy [1 ]
Liau, Linda M. [1 ]
Lai, Albert [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [31] Isocitrate Dehydrogenase (IDH1/IDH2) Mutation Types and Frequency in Periosteal Cartilaginous Tumors
    Carter, J. M.
    Voss, J. S.
    Kipp, B. R.
    Wenger, D. E.
    Inwards, C. Y.
    LABORATORY INVESTIGATION, 2013, 93 : 10A - 10A
  • [32] Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
    Murugan, A. K.
    Alzahrani, A. S.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2022, 79
  • [33] Mutant IDH1 and seizures in patients with glioma
    Chen, Hao
    Judkins, Jonathon
    Thomas, Cheddhi
    Wu, Meijing
    Khoury, Laith
    Benjamin, Carolina G.
    Pacione, Donato
    Golfinos, John G.
    Kumthekar, Priya
    Ghamsari, Farhad
    Chen, Li
    Lein, Pamela
    Chetkovich, Dane M.
    Snuderl, Matija
    Horbinski, Craig
    NEUROLOGY, 2017, 88 (19) : 1805 - 1813
  • [34] Isocitrate Dehydrogenase 1 and 2 (IDH1 and IDH2) Mutations in Solid Organ Malignancies by Next-Generation Sequencing
    Roy-Chowdhuri, S.
    Goswami, R. S.
    Chen, H.
    Routbort, M. J.
    Patel, K. P.
    Aldape, K.
    Lazar, A. J.
    Broaddus, R.
    Singh, R. R.
    Luthra, R.
    Kanagal-Shamanna, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 767 - 767
  • [35] PROBABLE ASSIGNMENT OF SOLUBLE ISOCITRATE DEHYDROGENASE (IDH1) TO 2Q33.3
    NARAHARA, K
    KIMURA, S
    KIKKAWA, K
    TAKAHASHI, Y
    WAKITA, Y
    KASAI, R
    NAGAI, S
    NISHIBAYASHI, Y
    KIMOTO, H
    HUMAN GENETICS, 1985, 71 (01) : 37 - 40
  • [36] Contrast enhancement as a prognostic factor in IDH1/2 mutant glioma.
    Suchorska, Bogdana
    Schueller, Ulrich
    Biczok, Annamaria
    Kreth, Friedrich Wilhelm
    Lenski, Markus
    Albert, Nathalie Lisa
    Giese, Armin
    Ertl-Wagner, Birgit
    Ingrisch, Michael
    Tonn, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] A single-tube, sensitive multiplex method for screening of isocitrate dehydrogenase 1 (IDH1) mutations
    Chou, Wen-Chien
    Huang, Yen-Ning
    Huang, Chi-Fei
    Tseng, Mei-Hsuan
    Tien, Hwei-Fang
    BLOOD, 2010, 116 (03) : 495 - 496
  • [38] Metabolism of glioma and IDH1/IDH2 mutations
    Rossetto, M.
    Ciccarino, P.
    Boisselier, B.
    Labussiere, M.
    Sanson, M.
    REVUE NEUROLOGIQUE, 2011, 167 (10) : 699 - 703
  • [39] Non-Small Cell Lung Cancer with Isocitrate Dehydrogenase (IDH1/IDH2) Mutations
    Toth, L. N.
    Peterson, J. D.
    de Abreu, F.
    Tsongalis, G. J.
    Tafe, L. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 1029 - 1029
  • [40] Elevated 2-Hydroxyglutarate (2-HG) in Human Glioma Samples Harboring the R132 Isocitrate Dehydrogenase 1 (IDH1) Mutation
    Chou, Arthur P.
    Lalezari, Shadi
    Lai, Albert
    Yang, Issac
    Buchanan, Colin
    Soto, Horacio
    Bi, Shuguang
    Prins, Robert M.
    Liau, Linda M.
    JOURNAL OF NEUROSURGERY, 2011, 115 (02) : A405 - A405
12345